Expression Constraint |
Valid Expression |
|
||||||||||||||||||||||||||||||||||||||
|
Precoordinated |
Postcoordinated |
||||||||||||||||||||||||||||||||||||||
< 19829001 |
disorder of lung |
: 116676008 |
associated morphology |
|
edema |
11468004 |
postoperative pulmonary edema |
210051003 |
injury to heart and lung |
: 116676008 |
associated morphology |
= |
edema |
|||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
276637009 |
hemorrhagic pulmonary edema |
|
|||||||||||||||||||||||||||||||||||||
< 19829001 |
disorder of lung |
: |
associated morphology |
|
edema |
233709006 |
toxic pulmonary edema |
275504005 |
lung cyst |
: |
associated morphology |
= |
inflammatory edema |
|||||||||||||||||||||||||||
|
233711002 |
oxygen-induced pulmonary edema |
19829001 |
disorder of lung |
: |
associated morphology |
= 40829002 |
acute edema |
||||||||||||||||||||||||||||||||
< 404684003 |
clinical finding |
: |
finding site |
|
pulmonary valve structure |
, |
associated morphology |
|
stenosis |
56786000 |
pulmonic valve stenosis |
|
56786000 |
pulmonic valve stenosis |
: |
finding site |
= |
structure of anulus fibrosus of pulmonary artery |
, |
associated morphology |
= |
partial stenosis |
||||||||||||||||||
|
86299006 |
tetralogy of Fallot |
404684003 |
clinical finding |
: |
finding site |
= 39057004 |
pulmonary valve structure |
, |
associated morphology |
|
stenosis |
||||||||||||||||||||||||||||
|
causative agent |
= 387517004 |
paracetamol |
295124009 |
paracetamol |
404684003 |
clinical finding |
: |
causative agent |
= 387517004 |
paracetamol |
|||||||||||||||||||||||||||||
|
292042007 |
adverse reaction to |
|
|||||||||||||||||||||||||||||||||||||
< 404684003 |
clinical finding |
: |
finding site |
|
pulmonary valve structure |
, |
associated morphology |
|
stenosis |
}, |
finding site |
|
right ventricular structure |
, |
associated morphology |
= << 56246009 |
hypertrophy |
} |
86299006 |
tetralogy of Fallot |
404684003 |
clinical finding |
: |
finding site |
= |
structure of cusp of pulmonic valve |
, |
associated morphology |
= |
stenosis |
}, |
finding site |
= 53085002 |
right ventricular structure |
, |
associated morphology |
= 125521000 |
acute hypertrophy |
} |
|
|
204351007 |
Fallot's trilogy |
|
|||||||||||||||||||||||||||||||||||||
< 404684003 |
clinical finding |
: |
associated with |
= |
clinical finding |
: |
associated morphology |
|
infarct |
) |
71023004 |
pericarditis secondary to acute myocardial infarction |
64572001 |
disease |
: |
associated with |
= |
clinical finding |
: |
associated morphology |
|
infarct |
, |
finding site |
= |
cardiac internal structure |
) |
|||||||||||||
<< 404684003 |
clinical finding |
: |
associated with |
= |
edema |
230580009 |
myxedema neuropathy |
95356008 |
mucosal ulcer |
: |
due to |
= |
acute edema |
|||||||||||||||||||||||||||
< 111115 |
amoxicillin tablet |
: |
has active ingredient |
|
amoxicillin |
, |
has reference basis of |
= 372687004 |
amoxicillin |
, |
strength magnitude equal to |
>= #500, |
strength unit |
= 258684004 |
mg |
} 1 |
111115 |
amoxicillin trihydrate 500 mg tablet |
8 |
111115 |
amoxicillin tablet |
: |
has dose form |
= |
oral tablet |
, |
has active ingredient |
= |
amoxicillin |
, |
has reference basis of strength |
|
amoxicillin |
, |
strength magnitude equal to |
|
strength unit |
= 258684004 |
mg |
}8 |
< 111115 |
amoxicillin tablet |
: |
has active ingredient |
= 372687004 |
amoxicillin |
, |
has reference basis of strength |
= 372687004 |
amoxicillin |
, |
strength magnitude equal to |
>= #500, |
strength magnitude equal to |
<= #800, |
strength unit |
= 258684004 |
mg |
}8 |
111115 |
amoxicillin trihydrate 750 mg tablet |
8 |
111115 |
amoxicillin tablet |
: |
has active ingredient |
= 372687004 |
amoxicillin |
, |
has reference basis of strength |
= 372687004 |
amoxicillin |
, |
strength magnitude equal to |
|
strength unit |
= 258684004 |
mg |
}8 |
||
< 373873005 |
pharmaceutical / biologic product |
: |
trade name |
= "PANADOL"8 |
111115 |
PANADOL [paracetamol] tablet |
8 |
373873005 |
pharmaceutical / biologic product |
: |
has active ingredient |
= |
paracetamol or derivative |
}, |
trade name |
= "PANADOL"8 |
||||||||||||||||||||||||
< 105590001 |
substance |
: |
has active ingredient |
|
TRIPHASIL tablet |
8 |
126109000 |
levonorgestrel |
- |
|||||||||||||||||||||||||||||||
|
126097006 |
ethinylestradiol |
|
|||||||||||||||||||||||||||||||||||||
< 404684003 |
clinical finding |
:
|
edema |
19242006 |
pulmonary edema |
404684003 |
clinical finding |
: |
associated morphology |
= 79654002 |
edema |
|||||||||||||||||||||||||||||
|
97341000119105 |
Proliferative retinopathy with retinal edema due to type 2 diabetes mellitus |
|
|||||||||||||||||||||||||||||||||||||
< 404684003 |
clinical finding |
: |
associated morphology |
= * |
19242006 |
pulmonary edema |
404684003 |
clinical finding |
: |
associated morphology |
= 79654002 |
edema |
||||||||||||||||||||||||||||
|
263225007 |
hip fracture |
404684003 |
clinical finding |
: |
associated morphology |
= 72704001 |
fracture |
Ref | Notes |
---|---|
1 | Please note that these examples are based on the draft drug concept model available at the time of writing. Concepts for which an identifier has not yet been assigned have been shown with an identifier of '111115'. |
Feedback